Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9769196 | European Journal of Medicinal Chemistry | 2005 | 9 Pages |
Abstract
Among the known non-benzodiazepinic hypnotic drugs acting on the α1 subunit of the GABA-A receptor, Zolpidem (2a), Zaleplon (1b) and Indiplon (1a) have showed high affinity and selectivity. Following a design methodology including pharmacophoric requirements and ADME-predicted properties, we have synthesized a library of 3-amino-4,5-dihydro-1H-pyrazolo[3,4-b]pyridin-6(7H)-ones (3) and their N1-alkyl derivatives (4) as new scaffolds for designing non-benzodiazepine BZ receptor ligands.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
José L. Falcó, Maia Lloveras, Irma Buira, Jordi Teixidó, José I. Borrell, Eva Méndez, José Terencio, Albert Palomer, Antonio Guglietta,